POS-799 EFFECT OF DARATUMUMAB/BORTEZOMIB/CYCLOPHOSPHAMIDE/DEXAMETHASONE ON RENAL FUNCTION AND HRQOL IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH RENAL INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Kidney International Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024921009785 |
id |
doaj-ff4d0b47037b440b81ae856a8c745800 |
---|---|
record_format |
Article |
spelling |
doaj-ff4d0b47037b440b81ae856a8c7458002021-04-18T06:32:10ZengElsevierKidney International Reports2468-02492021-04-0164S347POS-799 EFFECT OF DARATUMUMAB/BORTEZOMIB/CYCLOPHOSPHAMIDE/DEXAMETHASONE ON RENAL FUNCTION AND HRQOL IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH RENAL INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDYA. HAVASI0H.J. Lachmann1N. Leung2S. Kumar3A.J. Waxman4A.D. Wechalekar5K.S. Gries6X. Qin7H. Pei8N. Tran9B.M. Weiss10V. Sanchorawala11Boston University, School of Medicine, Boston, United StatesUniversity College London, n/a, London, United KingdomMayo Clinic Rochester, n/a, Rochester, United StatesMayo Clinic Rochester, n/a, Rochester, United StatesHospital of the University of Pennsylvania, n/a, Philadelphia, United StatesUniversity College London, n/a, London, United KingdomJanssen Research & Development- LLC, n/a, Raritan, United StatesJanssen Research & Development- LLC, n/a, Spring House, United StatesJanssen Research & Development- LLC, n/a, Titusville, United StatesJanssen Research & Development- LLC, n/a, Los Angeles, United StatesJanssen Research & Development- LLC, n/a, Spring House, United StatesBoston University, School of Medicine, Boston, United Stateshttp://www.sciencedirect.com/science/article/pii/S2468024921009785 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
A. HAVASI H.J. Lachmann N. Leung S. Kumar A.J. Waxman A.D. Wechalekar K.S. Gries X. Qin H. Pei N. Tran B.M. Weiss V. Sanchorawala |
spellingShingle |
A. HAVASI H.J. Lachmann N. Leung S. Kumar A.J. Waxman A.D. Wechalekar K.S. Gries X. Qin H. Pei N. Tran B.M. Weiss V. Sanchorawala POS-799 EFFECT OF DARATUMUMAB/BORTEZOMIB/CYCLOPHOSPHAMIDE/DEXAMETHASONE ON RENAL FUNCTION AND HRQOL IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH RENAL INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY Kidney International Reports |
author_facet |
A. HAVASI H.J. Lachmann N. Leung S. Kumar A.J. Waxman A.D. Wechalekar K.S. Gries X. Qin H. Pei N. Tran B.M. Weiss V. Sanchorawala |
author_sort |
A. HAVASI |
title |
POS-799 EFFECT OF DARATUMUMAB/BORTEZOMIB/CYCLOPHOSPHAMIDE/DEXAMETHASONE ON RENAL FUNCTION AND HRQOL IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH RENAL INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY |
title_short |
POS-799 EFFECT OF DARATUMUMAB/BORTEZOMIB/CYCLOPHOSPHAMIDE/DEXAMETHASONE ON RENAL FUNCTION AND HRQOL IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH RENAL INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY |
title_full |
POS-799 EFFECT OF DARATUMUMAB/BORTEZOMIB/CYCLOPHOSPHAMIDE/DEXAMETHASONE ON RENAL FUNCTION AND HRQOL IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH RENAL INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY |
title_fullStr |
POS-799 EFFECT OF DARATUMUMAB/BORTEZOMIB/CYCLOPHOSPHAMIDE/DEXAMETHASONE ON RENAL FUNCTION AND HRQOL IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH RENAL INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY |
title_full_unstemmed |
POS-799 EFFECT OF DARATUMUMAB/BORTEZOMIB/CYCLOPHOSPHAMIDE/DEXAMETHASONE ON RENAL FUNCTION AND HRQOL IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH RENAL INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY |
title_sort |
pos-799 effect of daratumumab/bortezomib/cyclophosphamide/dexamethasone on renal function and hrqol in patients with newly-diagnosed al amyloidosis with renal involvement: results from the phase 3 andromeda study |
publisher |
Elsevier |
series |
Kidney International Reports |
issn |
2468-0249 |
publishDate |
2021-04-01 |
url |
http://www.sciencedirect.com/science/article/pii/S2468024921009785 |
work_keys_str_mv |
AT ahavasi pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy AT hjlachmann pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy AT nleung pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy AT skumar pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy AT ajwaxman pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy AT adwechalekar pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy AT ksgries pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy AT xqin pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy AT hpei pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy AT ntran pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy AT bmweiss pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy AT vsanchorawala pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy |
_version_ |
1721523187955531776 |